A detailed history of Curbstone Financial Management Corp transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Curbstone Financial Management Corp holds 13,880 shares of CORT stock, worth $409,598. This represents 0.1% of its overall portfolio holdings.

Number of Shares
13,880
Holding current value
$409,598
% of portfolio
0.1%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 03, 2024

BUY
$22.21 - $34.48 $308,274 - $478,582
13,880 New
13,880 $450,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $3.16B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Curbstone Financial Management Corp Portfolio

Follow Curbstone Financial Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Curbstone Financial Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Curbstone Financial Management Corp with notifications on news.